Thyroid hormone resistance and pituitary enlargement after thyroid ablation in a woman on levothyroxine treatment

Thyroid

Volumn 18, Issue 10, 2008, Pages 1119-1123

  Marazuela, Monica ^a,c   Nattero, Lia ^a   Moure, Dolores ^a   García Polo, Iluminada ^a   Figueroa Vega, Nicte ^a   Guijarro, Carlos ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; GADOLINIUM; GLYCOPHORIN A; INDIUM 111; IODINE; LEVOTHYROXINE; NUCLEOTIDE; PROPYLTHIOURACIL; PROTIRELIN; RADIOACTIVE IODINE; SERINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; ECTOPIC HORMONE PRODUCTION; FALSE NEGATIVE RESULT; FEMALE; FREE THYROXINE INDEX; GENE SEQUENCE; HETEROZYGOTE; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS; HYPOPHYSIS TUMOR; HYPOTHYROIDISM; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROVOCATION TEST; SCINTISCANNING; THYROID FUNCTION TEST; THYROID HORMONE RESISTANCE; THYROID SURGERY; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; COMBINED MODALITY THERAPY; DRUG RESISTANCE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; HYPERPITUITARISM; HYPERTHYROIDISM; MIDDLE AGED; PITUITARY GLAND; SOMATOSTATIN; THYROID HORMONE RECEPTORS BETA; THYROXINE;

EID: 53649104039     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0375     Document Type: Article

References (15)

1. Refetoff S, Dumitrescu AM 2007 Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21:277-305.
2. Beck-Peccoz P, Persani L, Calebiro D, Bonomi M, Mannavola D, Campi I 2006 Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract Res Clin Endocrinol Metab 20:529-546.
3. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD 1999 Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476-486.
4. Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A 2003 The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442.
5. Foppiani L, Del Monte P, Ruelle A, Bandelloni R, Quilici P, Bernasconi D 2007 TSH-secreting adenomas: rare pituitary tumors with multifaceted clinical and biological features. J Endocrinol Invest 30:603-609.
6. Sarlis NJ, Gourgiotis L, Koch CA, Skarulis MC, Brucker-Davis F, Doppman JL, Oldfield EH, Patronas NJ 2003 MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation. AJR Am J Roentgenol 181:577-582.
7. Gurnell M, Rajanayagam O, Barbar I, Jones MK, Chatterjee VK 1998 Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid 8:679-682.
8. Safer JD, Colan SD, Fraser LM, Wondisford FE 2001 A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11:281-291.
9. Akiyoshi F, Okamura K, Fujikawa M, Sato K, Yoshinari M, Mizokami T, Hattori K, Kuwayama A, Takahashi Y, Fujishima M 1996 Difficulty in differentiating thyrotropin secreting pituitary microadenoma from pituitary-selective thyroid hormone resistance accompanied by pituitary incidentaloma. Thyroid 6:619-625.
10. Watanabe K, Kameya T, Yamauchi A, Yamamoto N, Kuwayama A, Takei I, Maruyama H, Saruta T 1993 Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 76:1025-1030.
11. Yamada T, Tsukui T, Ikejiri K, Yukimura Y, Kotani M 1976 Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab 42:817-822.
12. Moulik PK, Varma TR, Vora JP, Vinjamuri S 2002 The role of somatostatin receptor scintigraphy in the management of pituitary tumours. Nucl Med Commun 23:117-120.
13. Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P 2005 Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) 62:176-181.
14. Weiss RE, Weinberg M, Refetoff S 1993 Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest 91:2408-2415.
15. Hashimoto A, Shi Y, Drake K, Koh JT 2005 Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRbeta(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormone. Bioorg Med Chem 13:3627-3639.